Notice ID: 13906e25b8a34a8ca5744c528fbc690cSpecial NoticeArchived
Q--The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inf
Archived on September 19, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 10:00 AM EDT
- Posted
- August 28, 2026
- Notice type
- Special Notice
- NAICS
- 621511: Medical Laboratories
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NHLBI
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75N98026Q01067
- Notice ID
- 13906e25b8a34a8ca5744c528fbc690c
Description
The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
Notice_of_Intent_co_review_1.pdf
164 KBAdded in Special Notice version 3Posted
Lifecycle
- 3Version 3Special NoticeArchivedCurrent
Q--The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inf
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N98026Q01067
Archive Date
Sep 19, 2026
Office Address
BETHESDA, MD, 20892